In multivariate analyses, the models demonstrated limited stability due to the small sample size; however, IGF-1 SDS remained a negative predictor of RHI after adjustment for adiposity indices (BMI SDS and WHR) and key biochemical markers of metabolic syndrome (HDL cholesterol, triglycerides, and insulin). The gene discussed is INS; the disease is metabolic syndrome.